These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 28385068

  • 1. Transforming growth factor 15 increased in severe aplastic anemia patients.
    Shao Y, Wang H, Liu C, Cao Q, Fu R, Wang H, Wang T, Qi W, Shao Z.
    Hematology; 2017 Oct; 22(9):548-553. PubMed ID: 28385068
    [Abstract] [Full Text] [Related]

  • 2. Erythropoiesis-driven regulation of hepcidin in human red cell disorders is better reflected through concentrations of soluble transferrin receptor rather than growth differentiation factor 15.
    Fertrin KY, Lanaro C, Franco-Penteado CF, de Albuquerque DM, de Mello MR, Pallis FR, Bezerra MA, Hatzlhofer BL, Olbina G, Saad ST, da Silva Araújo A, Westerman M, Costa FF.
    Am J Hematol; 2014 Apr; 89(4):385-90. PubMed ID: 24860871
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Regulation of hepcidin through GDF-15 in cancer-related anemia.
    Jiang F, Yu WJ, Wang XH, Tang YT, Guo L, Jiao XY.
    Clin Chim Acta; 2014 Jan 20; 428():14-9. PubMed ID: 24384540
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Iron overload across the spectrum of non-transfusion-dependent thalassaemias: role of erythropoiesis, splenectomy and transfusions.
    Porter JB, Cappellini MD, Kattamis A, Viprakasit V, Musallam KM, Zhu Z, Taher AT.
    Br J Haematol; 2017 Jan 20; 176(2):288-299. PubMed ID: 27917462
    [Abstract] [Full Text] [Related]

  • 8. Growth differentiation factor-15 in young sickle cell disease patients: relation to hemolysis, iron overload and vascular complications.
    Tantawy AA, Adly AA, Ismail EA, Darwish YW, Ali Zedan M.
    Blood Cells Mol Dis; 2014 Dec 20; 53(4):189-93. PubMed ID: 25065856
    [Abstract] [Full Text] [Related]

  • 9. Serum iron metabolism and erythropoiesis in patients with myelodysplastic syndrome not receiving RBC transfusions.
    Cui R, Gale RP, Zhu G, Xu Z, Qin T, Zhang Y, Huang G, Li B, Fang L, Zhang H, Pan L, Hu N, Qu S, Xiao Z.
    Leuk Res; 2014 May 20; 38(5):545-50. PubMed ID: 24598841
    [Abstract] [Full Text] [Related]

  • 10. Iron Status in Newly Diagnosed β-Thalassemia Major: High Rate of Iron Status due to Erythropoiesis Drive.
    Susanah S, Rakhmilla LE, Ghozali M, Trisaputra JO, Moestopo O, Sribudiani Y, Idjradinata PS, Maskoen AM.
    Biomed Res Int; 2021 May 20; 2021():5560319. PubMed ID: 33954177
    [Abstract] [Full Text] [Related]

  • 11. GDF-15, iron, and inflammation in early chronic kidney disease among elderly patients.
    Lukaszyk E, Lukaszyk M, Koc-Zorawska E, Bodzenta-Lukaszyk A, Malyszko J.
    Int Urol Nephrol; 2016 Jun 20; 48(6):839-44. PubMed ID: 27043030
    [Abstract] [Full Text] [Related]

  • 12. The evaluation of iron overload through hepcidin level and its related factors in myelodysplastic syndromes.
    Gu S, Song X, Zhao Y, Guo J, Fei C, Xu F, Wu L, Zhang X, Zhao J, Chang C, Li X.
    Hematology; 2013 Sep 20; 18(5):286-94. PubMed ID: 23540794
    [Abstract] [Full Text] [Related]

  • 13. Acute-Phase Proteins and Iron Status in Cats with Chronic Kidney Disease.
    Javard R, Grimes C, Bau-Gaudreault L, Dunn M.
    J Vet Intern Med; 2017 Mar 20; 31(2):457-464. PubMed ID: 28140480
    [Abstract] [Full Text] [Related]

  • 14. [Study on abnormal iron metabolism and iron overload in patients with aplastic anemia].
    Jin P, Shi J, Li XX, Shao YQ, Nie N, Ge ML, Zhang J, Huang ZD, Huang JB, Zheng YZ.
    Zhonghua Xue Ye Xue Za Zhi; 2013 Oct 20; 34(10):877-82. PubMed ID: 24171963
    [Abstract] [Full Text] [Related]

  • 15. Erythropoiesis and Iron Homeostasis in Non-Transfusion-Dependent Thalassemia Patients with Extramedullary Hematopoiesis.
    Huang Y, Liu R, Wei X, Liu J, Pan L, Yang G, Lai Y.
    Biomed Res Int; 2019 Oct 20; 2019():4504302. PubMed ID: 30834265
    [Abstract] [Full Text] [Related]

  • 16. GDF15 is related to anemia and hepcidin in kidney allograft recipients.
    Malyszko J, Koc-Zorawska E, Malyszko JS, Glowinska I, Mysliwiec M, Macdougall IC.
    Nephron Clin Pract; 2013 Oct 20; 123(1-2):112-7. PubMed ID: 23797049
    [Abstract] [Full Text] [Related]

  • 17. Hepcidin and GDF-15 are potential biomarkers of iron deficiency anaemia in chronic kidney disease patients in South Africa.
    Nalado AM, Olorunfemi G, Dix-Peek T, Dickens C, Khambule L, Snyman T, Paget G, Mahlangu J, Duarte R, George J, Naicker S.
    BMC Nephrol; 2020 Sep 29; 21(1):415. PubMed ID: 32993549
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Iron chelation therapy and its influence on the alleviation of EPO resistance in MDS patients].
    Zhang Y, Xiao C, Gu SC, Chang CK.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug 29; 22(4):1027-32. PubMed ID: 25130822
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.